Literature DB >> 16683163

Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome.

Jian Xie1, Leonard Craig, Melanie H Cobb, Chou-Long Huang.   

Abstract

Gordon's syndrome, also known as pseudohypoaldosteronism type II (PHA II) or familial hypertension with hyperkalemia, is an autosomal-dominant disease characterized by hypertension, hyperkalemia, hyperchloremic metabolic acidosis, and normal glomerular filtration rate. Recent positional cloning has linked mutations of WNK1 and WNK4 to Gordon's syndrome. With-no-lysine [K] (WNK) kinases are a new family of large serine-threonine protein kinases with an atypical placement of the catalytic lysine. Here, we review the pathogenesis of PHA II based on current understanding of the actions of WNK1 and WNK4 on Na+ and K+ handling in the renal distal tubule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16683163     DOI: 10.1007/s00467-006-0106-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.

Authors:  B Xu; J M English; J L Wilsbacher; S Stippec; E J Goldsmith; M H Cobb
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 2.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension?

Authors:  Bernard C Rossier
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

4.  Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation.

Authors:  Jean-Michel Achard; David G Warnock; Sandra Disse-Nicodème; Béatrice Fiquet-Kempf; Pierre Corvol; Albert Fournier; Xavier Jeunemaitre
Journal:  Am J Med       Date:  2003-04-15       Impact factor: 4.965

5.  Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.

Authors:  D B Simon; F E Karet; J Rodriguez-Soriano; J H Hamdan; A DiPietro; H Trachtman; S A Sanjad; R P Lifton
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

6.  The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.

Authors:  Alberto C Vitari; Maria Deak; Nick A Morrice; Dario R Alessi
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 7.  An ATP-regulated, inwardly rectifying potassium channel from rat kidney (ROMK).

Authors:  S C Hebert
Journal:  Kidney Int       Date:  1995-10       Impact factor: 10.612

8.  Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.

Authors:  Haim Mayan; Iris Vered; Meir Mouallem; Michal Tzadok-Witkon; Rachel Pauzner; Zvi Farfel
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

9.  Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.

Authors:  Frederick H Wilson; Kristopher T Kahle; Ernesto Sabath; Maria D Lalioti; Alicia K Rapson; Robert S Hoover; Steven C Hebert; Gerardo Gamba; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

10.  Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.

Authors:  Brian P Zambrowicz; Alejandro Abuin; Ramiro Ramirez-Solis; Lizabeth J Richter; James Piggott; Hector BeltrandelRio; Eric C Buxton; Joel Edwards; Rick A Finch; Carl J Friddle; Anupma Gupta; Gwenn Hansen; Yi Hu; Wenhu Huang; Crystal Jaing; Billie Wayne Key; Peter Kipp; Buckley Kohlhauff; Zhi-Qing Ma; Diane Markesich; Robert Payne; David G Potter; Ny Qian; Joseph Shaw; Jeff Schrick; Zheng-Zheng Shi; Mary Jean Sparks; Isaac Van Sligtenhorst; Peter Vogel; Wade Walke; Nianhua Xu; Qichao Zhu; Christophe Person; Arthur T Sands
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more
  20 in total

1.  SLC26A9 is a Cl(-) channel regulated by the WNK kinases.

Authors:  Michael R Dorwart; Nikolay Shcheynikov; Youxue Wang; Steve Stippec; Shmuel Muallem
Journal:  J Physiol       Date:  2007-08-02       Impact factor: 5.182

2.  Deletion of Kir5.1 Impairs Renal Ability to Excrete Potassium during Increased Dietary Potassium Intake.

Authors:  Peng Wu; Zhong-Xiuzi Gao; Dan-Dan Zhang; Xiao-Tong Su; Wen-Hui Wang; Dao-Hong Lin
Journal:  J Am Soc Nephrol       Date:  2019-06-25       Impact factor: 10.121

Review 3.  WNK kinases and renal sodium transport in health and disease: an integrated view.

Authors:  James A McCormick; Chao-Ling Yang; David H Ellison
Journal:  Hypertension       Date:  2008-01-22       Impact factor: 10.190

4.  LINGO-1 interacts with WNK1 to regulate nogo-induced inhibition of neurite extension.

Authors:  Zhaohuan Zhang; Xiaohui Xu; Yong Zhang; Jianfeng Zhou; Zhongwang Yu; Cheng He
Journal:  J Biol Chem       Date:  2009-04-10       Impact factor: 5.157

5.  Hyperkalemia in young children: blood pressure checked?

Authors:  Richard Hollander; Geert Mortier; Koen van Hoeck
Journal:  Eur J Pediatr       Date:  2016-09-17       Impact factor: 3.183

Review 6.  WNK kinases and blood pressure control.

Authors:  Staci L Deaton; Samarpita Sengupta; Melanie H Cobb
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

7.  Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members.

Authors:  Charles J Heise; Bing-e Xu; Staci L Deaton; Seung-Kuy Cha; Chih-Jen Cheng; Svetlana Earnest; Samarpita Sengupta; Yu-Chi Juang; Steve Stippec; Yingda Xu; Yingming Zhao; Chou-Long Huang; Melanie H Cobb
Journal:  J Biol Chem       Date:  2010-06-04       Impact factor: 5.157

8.  WNK1 is required for mitosis and abscission.

Authors:  Szu-wei Tu; Abhijit Bugde; Katherine Luby-Phelps; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

9.  Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals.

Authors:  Samarpita Sengupta; Andrés Lorente-Rodríguez; Svetlana Earnest; Steve Stippec; Xiaofeng Guo; David C Trudgian; Hamid Mirzaei; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

10.  Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.

Authors:  Masoud Shekarabi; Nathalie Girard; Jean-Baptiste Rivière; Patrick Dion; Martin Houle; André Toulouse; Ronald G Lafrenière; Freya Vercauteren; Pascale Hince; Janet Laganiere; Daniel Rochefort; Laurence Faivre; Mark Samuels; Guy A Rouleau
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.